Studies with new drugs in the treatment of convulsive disorders.
D000328:Adult; D000374:Aggression; D000927:Anticonvulsants / Q000627:therapeutic use*; D001007:Anxiety; D002220:Carbamazepine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D005639:Frustration; D006212:Hallucinations; D006801:Humans; D008607:Intellectual Disability; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D009769:Object Attachment; D010468:Perceptual Disorders; D010640:Phenothiazines / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011599:Psychopathology; D012559:Schizophrenia; D013843:Thiazines / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000927:Anticonvulsants; D003984:Dibenzazepines; D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D013843:Thiazines; D014149:Tranquilizing Agents; D002220:Carbamazepine; D003975:Diazepam